Neuromeka recorded a single insider purchase during the past ninety days. Director Gim Jeong A acquired shares valued at approximately 19.89 million KRW on September 7, 2026. This transaction represents the sole activity observed, occurring amidst a period where the stock price experienced an 8.7% decline.